Star founders, investigators huddle around new Boston accelerator spotlighting young entrepreneurs
As a widely recognized biotech hub, Boston is undoubtedly one of the best places to start a new company at the frontier of biology and engineering. With a dense network of incubators, venture capitalists and talent, seasoned company founders can have their pick of partners and models launching their latest startups.
But for young, aspiring entrepreneurs, it’s a very different scene.
Big VC firms might hire you to work on their ideas instead of yours, and accelerators may not offer the kind of deep technical expertise and guidance needed to make it in the field.
“There was no formal path, and really, there was no ecosystem,” Brian Baynes recalled about joining Flagship Pioneering 15 years ago, fresh out of his PhD program, after finding “that tiny little crack in the wall” from academia.
While most of his brightest classmates back then would have been set on becoming professors, today MIT and Harvard are full of students who are keen to translate what they do in their labs into the real world. That’s why Baynes is teaming up with Tony Kulesa — who’s just finished a PhD in biological engineering — and longtime investor Jamie Goldstein to launch Petri, an accelerator built to support a broad swath of biological innovation.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 105,400+ biopharma pros reading Endpoints daily — and it's free.